PT - JOURNAL ARTICLE AU - Cheng Wang AU - Katie R Mollan AU - Michael G Hudgens AU - Joseph D Tucker AU - Heping Zheng AU - Weiming Tang AU - Li Ling TI - Generalisability of an online randomised controlled trial: an empirical analysis AID - 10.1136/jech-2017-209976 DP - 2018 Feb 01 TA - Journal of Epidemiology and Community Health PG - 173--178 VI - 72 IP - 2 4099 - http://jech.bmj.com/content/72/2/173.short 4100 - http://jech.bmj.com/content/72/2/173.full SO - J Epidemiol Community Health2018 Feb 01; 72 AB - Background Investigators increasingly use online methods to recruit participants for randomised controlled trials (RCTs). However, the extent to which participants recruited online represent populations of interest is unknown. We evaluated how generalisable an online RCT sample is to men who have sex with men in China.Methods Inverse probability of sampling weights (IPSW) and the G-formula were used to examine the generalisability of an online RCT using model-based approaches. Online RCT data and national cross-sectional study data from China were analysed to illustrate the process of quantitatively assessing generalisability. The RCT (identifier NCT02248558) randomly assigned participants to a crowdsourced or health marketing video for promotion of HIV testing. The primary outcome was self-reported HIV testing within 4 weeks, with a non-inferiority margin of −3%.Results In the original online RCT analysis, the estimated difference in proportions of HIV tested between the two arms (crowdsourcing and health marketing) was 2.1% (95% CI, −5.4% to 9.7%). The hypothesis that the crowdsourced video was not inferior to the health marketing video to promote HIV testing was not demonstrated. The IPSW and G-formula estimated differences were −2.6% (95% CI, −14.2 to 8.9) and 2.7% (95% CI, −10.7 to 16.2), with both approaches also not establishing non-inferiority.Conclusions Conducting generalisability analysis of an online RCT is feasible. Examining the generalisability of online RCTs is an important step before an intervention is scaled up.Trial registration number NCT02248558.